1. It's just a pilot study, and outpatient at that. 2. N = 42 is .. small.. but see: #1 3. Holy crap that's fascinating results!! Wow! Can't wait to see wha

1. It's just a pilot study, and outpatient at that. 2. N = 42 is .. small.. but see: #1 3. Holy crap that's fascinating results!! Wow! Can't wait to see what happens in a Real study (RCT) with higher N. 4. I'm smirking at the fact that the authors consist of the employees of the company that makes the compound in question, and those with the most to gain. But this in no way diminishes point #3. 5. Where did you hear of this? I'm disappointed in myself that I hadn't seen this, and it's from the middle of last year.